nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RXRB—Vitamin D Metabolism—GC—Graves' disease	0.0382	0.346	CbGpPWpGaD
Acitretin—Neuritis—Methimazole—Graves' disease	0.0354	0.0658	CcSEcCtD
Acitretin—RBP1—eye—Graves' disease	0.0338	0.0963	CbGeAlD
Acitretin—Ageusia—Methimazole—Graves' disease	0.0327	0.0607	CcSEcCtD
Acitretin—RXRG—eye—Graves' disease	0.0306	0.0871	CbGeAlD
Acitretin—Neuritis—Propylthiouracil—Graves' disease	0.0301	0.056	CcSEcCtD
Acitretin—Skin ulcer—Propylthiouracil—Graves' disease	0.0289	0.0537	CcSEcCtD
Acitretin—Ageusia—Propylthiouracil—Graves' disease	0.0278	0.0516	CcSEcCtD
Acitretin—RARG—eye—Graves' disease	0.0255	0.0727	CbGeAlD
Acitretin—RBP1—pituitary gland—Graves' disease	0.0251	0.0715	CbGeAlD
Acitretin—RBP1—adipose tissue—Graves' disease	0.025	0.0712	CbGeAlD
Acitretin—Vasculitis—Propylthiouracil—Graves' disease	0.0231	0.0428	CcSEcCtD
Acitretin—RXRG—pituitary gland—Graves' disease	0.0227	0.0647	CbGeAlD
Acitretin—RXRG—adipose tissue—Graves' disease	0.0226	0.0644	CbGeAlD
Acitretin—RBP1—thyroid gland—Graves' disease	0.0216	0.0616	CbGeAlD
Acitretin—RARB—thyroid gland—Graves' disease	0.02	0.057	CbGeAlD
Acitretin—RXRA—Vitamin D Metabolism—GC—Graves' disease	0.0199	0.18	CbGpPWpGaD
Acitretin—RXRG—thyroid gland—Graves' disease	0.0196	0.0557	CbGeAlD
Acitretin—RARG—adipose tissue—Graves' disease	0.0189	0.0537	CbGeAlD
Acitretin—RXRB—thyroid gland—Graves' disease	0.0184	0.0524	CbGeAlD
Acitretin—RARA—pituitary gland—Graves' disease	0.0178	0.0507	CbGeAlD
Acitretin—RARA—adipose tissue—Graves' disease	0.0177	0.0505	CbGeAlD
Acitretin—Dermatitis exfoliative—Propylthiouracil—Graves' disease	0.0173	0.0322	CcSEcCtD
Acitretin—RARG—thyroid gland—Graves' disease	0.0163	0.0465	CbGeAlD
Acitretin—RARA—thyroid gland—Graves' disease	0.0154	0.0437	CbGeAlD
Acitretin—Neuropathy peripheral—Methimazole—Graves' disease	0.0145	0.027	CcSEcCtD
Acitretin—Jaundice—Methimazole—Graves' disease	0.0144	0.0268	CcSEcCtD
Acitretin—Hepatitis—Methimazole—Graves' disease	0.0133	0.0247	CcSEcCtD
Acitretin—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.0123	0.0229	CcSEcCtD
Acitretin—Jaundice—Propylthiouracil—Graves' disease	0.0123	0.0228	CcSEcCtD
Acitretin—Alopecia—Methimazole—Graves' disease	0.0117	0.0218	CcSEcCtD
Acitretin—Haemoglobin—Propylthiouracil—Graves' disease	0.0114	0.0211	CcSEcCtD
Acitretin—Hepatitis—Propylthiouracil—Graves' disease	0.0113	0.021	CcSEcCtD
Acitretin—Haemorrhage—Propylthiouracil—Graves' disease	0.0113	0.021	CcSEcCtD
Acitretin—Alopecia—Propylthiouracil—Graves' disease	0.00998	0.0185	CcSEcCtD
Acitretin—Myalgia—Methimazole—Graves' disease	0.00985	0.0183	CcSEcCtD
Acitretin—Arthralgia—Methimazole—Graves' disease	0.00985	0.0183	CcSEcCtD
Acitretin—Dysgeusia—Propylthiouracil—Graves' disease	0.00963	0.0179	CcSEcCtD
Acitretin—Oedema—Methimazole—Graves' disease	0.00944	0.0175	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Methimazole—Graves' disease	0.0086	0.016	CcSEcCtD
Acitretin—Paraesthesia—Methimazole—Graves' disease	0.00848	0.0157	CcSEcCtD
Acitretin—Somnolence—Methimazole—Graves' disease	0.00839	0.0156	CcSEcCtD
Acitretin—Arthralgia—Propylthiouracil—Graves' disease	0.00837	0.0156	CcSEcCtD
Acitretin—Myalgia—Propylthiouracil—Graves' disease	0.00837	0.0156	CcSEcCtD
Acitretin—Dyspepsia—Methimazole—Graves' disease	0.00831	0.0154	CcSEcCtD
Acitretin—Oedema—Propylthiouracil—Graves' disease	0.00803	0.0149	CcSEcCtD
Acitretin—Urticaria—Methimazole—Graves' disease	0.0075	0.0139	CcSEcCtD
Acitretin—Body temperature increased—Methimazole—Graves' disease	0.00746	0.0139	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00731	0.0136	CcSEcCtD
Acitretin—Paraesthesia—Propylthiouracil—Graves' disease	0.00721	0.0134	CcSEcCtD
Acitretin—Somnolence—Propylthiouracil—Graves' disease	0.00714	0.0133	CcSEcCtD
Acitretin—Dyspepsia—Propylthiouracil—Graves' disease	0.00707	0.0131	CcSEcCtD
Acitretin—Pruritus—Methimazole—Graves' disease	0.00668	0.0124	CcSEcCtD
Acitretin—Urticaria—Propylthiouracil—Graves' disease	0.00638	0.0118	CcSEcCtD
Acitretin—Body temperature increased—Propylthiouracil—Graves' disease	0.00635	0.0118	CcSEcCtD
Acitretin—Vomiting—Methimazole—Graves' disease	0.006	0.0112	CcSEcCtD
Acitretin—Rash—Methimazole—Graves' disease	0.00595	0.0111	CcSEcCtD
Acitretin—Dermatitis—Methimazole—Graves' disease	0.00595	0.011	CcSEcCtD
Acitretin—Headache—Methimazole—Graves' disease	0.00591	0.011	CcSEcCtD
Acitretin—Pruritus—Propylthiouracil—Graves' disease	0.00568	0.0105	CcSEcCtD
Acitretin—Nausea—Methimazole—Graves' disease	0.00561	0.0104	CcSEcCtD
Acitretin—Vomiting—Propylthiouracil—Graves' disease	0.0051	0.00948	CcSEcCtD
Acitretin—Rash—Propylthiouracil—Graves' disease	0.00506	0.0094	CcSEcCtD
Acitretin—Dermatitis—Propylthiouracil—Graves' disease	0.00506	0.00939	CcSEcCtD
Acitretin—Headache—Propylthiouracil—Graves' disease	0.00503	0.00934	CcSEcCtD
Acitretin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCGB3A2—Graves' disease	0.00499	0.0452	CbGpPWpGaD
Acitretin—Nausea—Propylthiouracil—Graves' disease	0.00477	0.00886	CcSEcCtD
Acitretin—RXRA—Orphan transporters—GABRA3—Graves' disease	0.00285	0.0258	CbGpPWpGaD
Acitretin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.00274	0.0248	CbGpPWpGaD
Acitretin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.00251	0.0227	CbGpPWpGaD
Acitretin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.00246	0.0223	CbGpPWpGaD
Acitretin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.00236	0.0214	CbGpPWpGaD
Acitretin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.00236	0.0214	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—FAS—Graves' disease	0.00215	0.0195	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—FAS—Graves' disease	0.00163	0.0148	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—FAS—Graves' disease	0.00153	0.0139	CbGpPWpGaD
Acitretin—RXRA—Transcription factor regulation in adipogenesis—TNF—Graves' disease	0.0014	0.0127	CbGpPWpGaD
Acitretin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Graves' disease	0.00123	0.0111	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.00122	0.011	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.00118	0.0106	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.00117	0.0106	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.00113	0.0102	CbGpPWpGaD
Acitretin—RBP1—Disease—B3GNT2—Graves' disease	0.00105	0.00948	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GC—Graves' disease	0.000943	0.00854	CbGpPWpGaD
Acitretin—CYP26A1—Adipogenesis—TNF—Graves' disease	0.000913	0.00827	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—FAS—Graves' disease	0.000799	0.00723	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000786	0.00712	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—B3GNT2—Graves' disease	0.000714	0.00647	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000695	0.00629	CbGpPWpGaD
Acitretin—RXRG—Adipogenesis—TNF—Graves' disease	0.000692	0.00627	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	0.000664	0.00601	CbGpPWpGaD
Acitretin—RARA—Adipogenesis—TNF—Graves' disease	0.000651	0.00589	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	0.000609	0.00551	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TSHR—Graves' disease	0.000607	0.0055	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	0.000587	0.00532	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—ICAM1—Graves' disease	0.00054	0.00489	CbGpPWpGaD
Acitretin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—Graves' disease	0.000516	0.00467	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	0.000505	0.00458	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000499	0.00452	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000478	0.00433	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	0.000451	0.00408	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	0.000429	0.00389	CbGpPWpGaD
Acitretin—RBP1—Disease—HLA-A—Graves' disease	0.000423	0.00383	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IFNG—Graves' disease	0.000411	0.00372	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CXCL10—Graves' disease	0.000392	0.00355	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—IL1B—Graves' disease	0.000367	0.00332	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	0.000359	0.00325	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GC—Graves' disease	0.00035	0.00317	CbGpPWpGaD
Acitretin—RXRA—Adipogenesis—TNF—Graves' disease	0.000339	0.00307	CbGpPWpGaD
Acitretin—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	0.000327	0.00296	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	0.000327	0.00296	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000317	0.00287	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—IL2RA—Graves' disease	0.0003	0.00272	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	0.000291	0.00264	CbGpPWpGaD
Acitretin—RBP1—Disease—CD4—Graves' disease	0.000273	0.00247	CbGpPWpGaD
Acitretin—ALB—Folate Metabolism—TNF—Graves' disease	0.000266	0.00241	CbGpPWpGaD
Acitretin—RXRA—Metabolism—B3GNT2—Graves' disease	0.000265	0.0024	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	0.000249	0.00226	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	0.000237	0.00215	CbGpPWpGaD
Acitretin—ALB—Selenium Micronutrient Network—TNF—Graves' disease	0.000211	0.00191	CbGpPWpGaD
Acitretin—ALB—Metabolism—GC—Graves' disease	0.00016	0.00145	CbGpPWpGaD
Acitretin—ALB—Hemostasis—IL2RA—Graves' disease	0.000122	0.00111	CbGpPWpGaD
Acitretin—ALB—Metabolism—B3GNT2—Graves' disease	0.000121	0.0011	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—TNF—Graves' disease	0.000117	0.00106	CbGpPWpGaD
